63539-193 : Bosulif 400 mg Oral Tablet, Film Coated


NDC: 63539-193
Labeler: U.S. Pharmaceuticals
Product Type: Human Prescription Drug
Drug Name:  Bosulif
Dosage Form: Oral Tablet, Film Coated
Application #: NDA203341
Rev. Date: 


NDC Package Codes:

  • 63539-193-30: 30 TABLET, FILM COATED IN 1 BOTTLE (63539‑193‑30)

Active Ingredients:

  • Bosutinib Monohydrate

Dosage Strength:

  • 400 mg

Pharmaceutical Classes:

  • Bcr-Abl Tyrosine Kinase Inhibitors [MoA]
  • Kinase Inhibitor [EPC]

Related Products:

Based on records with the same trade name.
  • 63539-117 Bosulif 100 mg Oral Tablet, Film Coated by U.S. Pharmaceuticals
  • 0069-0135 Bosulif 100 mg Oral Tablet by Pfizer Laboratories Div Pfizer Inc
  • 0069-0136 Bosulif 500 mg Oral Tablet by Pfizer Laboratories Div Pfizer Inc
  • 0069-0193 Bosulif 400 mg Oral Tablet, Film Coated by Pfizer Laboratories Div Pfizer Inc
  • 0069-0504 Bosulif 50 mg Oral Capsule by Pfizer Laboratories Div Pfizer Inc
  • 0069-1014 Bosulif 100 mg Oral Capsule by Pfizer Laboratories Div Pfizer Inc

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 63539-193 QR Code

< Prev: 63539-189Next: 63539-197 >

Related Discussions:

chest pain while taking bosulif
I have been taking bosulif for a little over a year now. I first started with 300 mg with very few side effects. About 1... 1 reply
Patient assistance income guidelines for Bosulif
Does anyone know the income guidelines for the patient assistance program for Bosulif? ## @Jake, Interestingly enough, P... 1 reply




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.